Unlocking Tissue Resident Immunity For Solid Tumor Therapy
TCura Bioscience leverages novel discoveries in the field of T-Cell Memory to identify and validate new immunotherapy targets. We are committed to developing first-in-class therapies to transform the treatment of solid tumors.
Founding Team
-
Amir Ferry
CO-FOUNDER & CEO
PhD Candidate | Goldrath Lab | UC San Diego
-
Ananda Goldrath, Ph.D.
CO-FOUNDER
Executive VP & Director | the Allen Institute for Immunology
-
Miguel Reina-Campos, Ph.D.
CO-FOUNDER
Assistant Professor | La Jolla Institute for Immunology
Company News
-
BioLabs Investor Day
March 2024
TCura Bioscience was selected to pitch at the inaugural BioLabs Investor Day.
-
Platinum Program
October 2023
TCura Bioscience chosen as a Finalist for the Mission BioCapital Platinum Program
-
Company Founding
August 2023
TCura Bio founded to advance next-gen immuno-oncology medicines.
Scientific Advisors
-
Ananda Goldrath, Ph.D.
Executive VP & Director | the Allen Institute for Immunology
-
Hongbo Chi, Ph.D.
Endowed Chair, St Jude Children’s Research Hospital
-
Laura Mackay, Ph.D.
Professor| Doherty Institute | University of Melbourne